Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 393

1.

Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, Whiteman DC, Corley DA.

Gastroenterology. 2012 Apr;142(4):744-53. doi: 10.1053/j.gastro.2011.12.049. Epub 2012 Jan 11.

2.

A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.

Dai JY, de Dieu Tapsoba J, Buas MF, Onstad LE, Levine DM, Risch HA, Chow WH, Bernstein L, Ye W, Lagergren J, Bird NC, Corley DA, Shaheen NJ, Wu AH, Reid BJ, Hardie LJ, Whiteman DC, Vaughan TL.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1739-47. doi: 10.1158/1055-9965.EPI-15-0507. Epub 2015 Sep 16.

3.

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.

Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2481-6.

4.

Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON).

Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch HA, Casson AG, Freedman ND, Chow WH, Wu AH, Bernstein L, Nyrén O, Pandeya N, Whiteman DC, Vaughan TL.

PLoS One. 2014 Jul 30;9(7):e103508. doi: 10.1371/journal.pone.0103508. eCollection 2014.

5.

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ.

Am J Gastroenterol. 2002 Aug;97(8):1930-6.

PMID:
12190156
6.

Risk factors in the development of esophageal adenocarcinoma.

Pohl H, Wrobel K, Bojarski C, Voderholzer W, Sonnenberg A, Rösch T, Baumgart DC.

Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18.

PMID:
23247577
7.

Risk factors, DNA damage, and disease progression in Barrett's esophagus.

Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5.

8.

Smoking and Barrett's esophagus in women who undergo upper endoscopy.

Jacobson BC, Giovannucci EL, Fuchs CS.

Dig Dis Sci. 2011 Jun;56(6):1707-17. doi: 10.1007/s10620-011-1672-4. Epub 2011 Mar 30.

9.

Cigarette smoking and the risk of Barrett's esophagus.

Kubo A, Levin TR, Block G, Rumore G, Quesenberry CP Jr, Buffler P, Corley DA.

Cancer Causes Control. 2009 Apr;20(3):303-11. doi: 10.1007/s10552-008-9244-4. Epub 2008 Oct 14.

10.

Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma.

Avidan B, Sonnenberg A, Schnell TG, Sontag SJ.

Gastroenterology. 2001 Dec;121(6):1281-5.

PMID:
11729106
11.

Barrett's esophagus and the risk of obstructive sleep apnea: a case-control study.

Cummings LC, Shah N, Maimone S, Salah W, Khiani V, Chak A.

BMC Gastroenterol. 2013 May 11;13:82. doi: 10.1186/1471-230X-13-82.

12.

Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.

Brown CS, Lapin B, Wang C, Goldstein JL, Linn JG, Denham W, Haggerty SP, Talamonti MS, Howington JA, Carbray J, Ujiki MB.

Surg Endosc. 2015 Dec;29(12):3528-34. doi: 10.1007/s00464-015-4103-3. Epub 2015 Feb 13.

PMID:
25676204
13.

Etiology of Barrett's metaplasia and esophageal adenocarcinoma.

Kim R, Weissfeld JL, Reynolds JC, Kuller LH.

Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):369-77. Review.

14.

Gastroesophageal reflux disease: From heartburn to cancer.

Patti MG, Waxman I.

World J Gastroenterol. 2010 Aug 14;16(30):3743-4.

15.

Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium.

Thrift AP, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Whiteman DC, Shaheen NJ, Corley DA.

Am J Gastroenterol. 2014 Oct;109(10):1586-94. doi: 10.1038/ajg.2014.206. Epub 2014 Jul 22.

16.

Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.

Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA.

Am J Gastroenterol. 2016 Nov;111(11):1528-1535. doi: 10.1038/ajg.2016.348. Epub 2016 Aug 30.

17.

The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.

Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ, Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyrén O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow WH, Ward MH, Freedman ND, Whiteman DC.

Cancer Epidemiol. 2012 Jun;36(3):306-16. doi: 10.1016/j.canep.2012.03.001. Epub 2012 Apr 13.

18.

Barrett's esophagus and medications that relax the lower esophageal sphincter.

Corley DA, Levin TR, Habel LA, Buffler PA.

Am J Gastroenterol. 2006 May;101(5):937-44.

PMID:
16573773
19.

Risk factors for Barrett's esophagus.

Rubenstein JH.

Curr Opin Gastroenterol. 2014 Jul;30(4):408-14. doi: 10.1097/MOG.0000000000000084. Review.

PMID:
24859804
20.

From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.

Wang RH.

World J Gastroenterol. 2015 May 7;21(17):5210-9. doi: 10.3748/wjg.v21.i17.5210. Review.

Supplemental Content

Support Center